NCT06235177 · Early Phase 1 · NOT YET RECRUITING

Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues

This early Phase 1 trial is testing a bundle of non-drug approaches — herbal tinctures, yoga, mental imagery, relaxation techniques, and a faith-based psychological assessment — under a framework the researchers call Psychoneuromentalism Disorder. It is an extremely early stage, meaning it has not yet established basic safety or effectiveness. The source material is thin and the underlying condition being defined is not standard medical terminology.

You may qualify if

  • Clinical Diagnosis of anxiety, schizoaffective disorder, bipolar disorder, ADHD, Dementia, or other psychological issues and disorders; autoimmune disease such as fibromyalgia, lupus, and thyroid disease, neuropathy and chronic fatigue syndrome
  • Must be able to swallow tablets

You're excluded if

  • Children under the age of 18
  • Must not be on any blood thinner medications
  • Chronically ill patients

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-08-12

View full record on ClinicalTrials.gov

All APOE4 clinical trials